Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kim Henriksen

Showing results (41-50 of 154) with videos related to

Pageof 16
Sort By:
European Journal of Pharmacology|December 6, 2023
OXM-104, a potential candidate for the treatment of obesity, NASH and type 2 diabetesSimone Anna Melander, Ashref Kayed, Kim Vietz Andreassen, et al.
Bone|March 30, 2016
Zoledronate prevents lactation induced bone loss and results in additional post-lactation bone mass in miceMette Høegh Wendelboe, Jesper Skovhus Thomsen, Kim Henriksen, et al.
Plos One|November 7, 2019
A caspase-6-cleaved fragment of Glial Fibrillary Acidic Protein as a potential serological biomarker of CNS injury after cardiac arrestDitte S Jonesco, Christian Hassager, Martin Frydland, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 23, 2020
The Calcitonin Receptor Plays a Major Role in Glucose Regulation as a Function of Dual Amylin and Calcitonin Receptor Agonist TherapyAnna Thorsø Larsen, Nina Sonne, Kim Vietz Andreassen, et al.
Frontiers in Neurology|January 15, 2025
Diagnostic potential of blood-based biomarkers in multiple sclerosisSigne Holm Nielsen, Morten Karsdal, Bruna Manoel, et al.
Assay and Drug Development Technologies|November 8, 2011
Tumor necrosis factor-α and receptor activator of nuclear factor-κB ligand augment human macrophage foam-cell destruction of extracellular matrix through protease-mediated processesHelene Skjøt-Arkil, Natasha Barascuk, Lise Larsen, et al.
Biochemical and Biophysical Research Communications|December 11, 2007
Osteoclasts secrete non-bone derived signals that induce bone formationMorten A Karsdal, Anita V Neutzsky-Wulff, Morten H Dziegiel, et al.
Plos One|April 12, 2018
Two novel blood-based biomarker candidates measuring degradation of tau are associated with dementia: A prospective studyJesper Skov Neergaard, Katrine Dragsbæk, Claus Christiansen, et al.
Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals|June 1, 2013
Quantification of "end products" of tissue destruction in inflammation may reflect convergence of cytokine and signaling pathways -- implications for modern clinical chemistryMorten A Karsdal, Anne Christine Bay-Jensen, Diana Julie Leeming, et al.
Biochemical and Biophysical Research Communications|July 17, 2007
Dissolution of the inorganic phase of bone leading to release of calcium regulates osteoclast survivalRasmus H Nielsen, Morten A Karsdal, Mette G Sørensen, et al.
Pageof 16

Showing results (41-50 of 154) with videos related to

Sort By:
Pageof 16
European Journal of Pharmacology|December 6, 2023
OXM-104, a potential candidate for the treatment of obesity, NASH and type 2 diabetesSimone Anna Melander, Ashref Kayed, Kim Vietz Andreassen, et al.
Bone|March 30, 2016
Zoledronate prevents lactation induced bone loss and results in additional post-lactation bone mass in miceMette Høegh Wendelboe, Jesper Skovhus Thomsen, Kim Henriksen, et al.
Plos One|November 7, 2019
A caspase-6-cleaved fragment of Glial Fibrillary Acidic Protein as a potential serological biomarker of CNS injury after cardiac arrestDitte S Jonesco, Christian Hassager, Martin Frydland, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 23, 2020
The Calcitonin Receptor Plays a Major Role in Glucose Regulation as a Function of Dual Amylin and Calcitonin Receptor Agonist TherapyAnna Thorsø Larsen, Nina Sonne, Kim Vietz Andreassen, et al.
Frontiers in Neurology|January 15, 2025
Diagnostic potential of blood-based biomarkers in multiple sclerosisSigne Holm Nielsen, Morten Karsdal, Bruna Manoel, et al.
Assay and Drug Development Technologies|November 8, 2011
Tumor necrosis factor-α and receptor activator of nuclear factor-κB ligand augment human macrophage foam-cell destruction of extracellular matrix through protease-mediated processesHelene Skjøt-Arkil, Natasha Barascuk, Lise Larsen, et al.
Biochemical and Biophysical Research Communications|December 11, 2007
Osteoclasts secrete non-bone derived signals that induce bone formationMorten A Karsdal, Anita V Neutzsky-Wulff, Morten H Dziegiel, et al.
Plos One|April 12, 2018
Two novel blood-based biomarker candidates measuring degradation of tau are associated with dementia: A prospective studyJesper Skov Neergaard, Katrine Dragsbæk, Claus Christiansen, et al.
Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals|June 1, 2013
Quantification of "end products" of tissue destruction in inflammation may reflect convergence of cytokine and signaling pathways -- implications for modern clinical chemistryMorten A Karsdal, Anne Christine Bay-Jensen, Diana Julie Leeming, et al.
Biochemical and Biophysical Research Communications|July 17, 2007
Dissolution of the inorganic phase of bone leading to release of calcium regulates osteoclast survivalRasmus H Nielsen, Morten A Karsdal, Mette G Sørensen, et al.
Pageof 16